latanyaworkman

المسارات 0
متابعون1
التالية4

الذكر
روابط اجتماعية
السيرة الذاتية
Calof et al reported no deaths in the testosterone group, but there were 2 deaths, of unspecified etiology, in the placebo group.146 It was only the sum of all the above‐mentioned prostate‐related adverse events that significantly differed from the placebo group in Calof's meta‐analysis. This included cases of prostate cancer, which showed no significant difference between the testosterone group and the placebo group.
Early detection helps prevent serious problems and keeps therapy safe. Any new symptoms like chest pain, dizziness, shortness of breath, or strong heartbeats (palpitations) should be reported right away. Monitoring may include repeated ECGs, echocardiograms, or blood tests. Certain changes can help lower the chance of heart problems and reduce symptoms like a fast heartbeat. Doctors make these decisions based on individual health history, test results, and how the person feels. If someone notices a fast or irregular heartbeat after starting TRT, a doctor may recommend further heart testing.
The effect of testosterone on these parameters in various populations has been the subject of debate in many meta-analyses.71 However, due to the nature of the studies, reverse causality cannot be ruled out. Nettleship et al.65 found that testosterone slows atheroma development and reverses lipid deposition in the artery wall. It is believed that this process involves the downregulation of L-type voltage-gated calcium channels61 and upregulation of calcium-activated potassium channels.62 The immediacy of the vasodilation has raised questions as to whether the underlying mechanism involves non-genomic actions of testosterone. BMI, body mass index; Ca, calcium; H, hydrogen; HbA1c, hemoglobin A1c; hs-CRP, high-sensitivity C-reactive protein; K, potassium; O, oxygen; OH, hydroxide; QTc interval, heart-rate–corrected QT interval.
The meta-analysis revealed that patients treated with T experienced a 16.7% increase (equivalent to ~ 54 m) in the 6-minute walk test, a 15.9% increase in the isometric walk test, and a 22.7% increase in peak VO2. All three found that in men with CAD, testosterone prolongs the time to exercise-induced ST-segment depression as measured on treadmill stress testing.24–26 Testosterone has been reported to have direct vasodilatory effects on coronary arteries in men with CAD.26 The authors also verified that the odds ratio for having hypogonadism was significantly higher in obese men, and there was a statistically significant negative correlation between total T level and BMI.15 Testosterone replacement therapy (TRT) has been shown to decrease fat mass.
There are several health risks with excessively high free testosterone, and I spent a few hours with a doctor friend to look at the scientific evidence for heart problems such as chronically increased heart rate. Managing the possible effects of testosterone therapy on the heart, especially an increased heart rate, requires careful planning. Basaria et al evaluated the safety and efficacy of daily application of transdermal testosterone gel in 209 men.150 Given the increased rate of adverse cardiovascular events in the testosterone group, the study was stopped prematurely. Peak VO2 and peak O2 pulse, both of which offer an accurate reflection of aerobic exercise capacity, were shown to have a positive and statistically significant association with testosterone levels in multivariable‐adjusted models.139 This indicates that the association between circulating testosterone levels and aerobic exercise capacity in CHF patients is most likely independent of heart failure severity, beta‐blocker use, and chronotropic response to exercise. Finally, Jankowska et al demonstrated that reduced levels of total and estimated free testosterone were both predictors of increased mortality in men with CHF.137 Similar findings have been reported by other investigators as well.
In the cardiovascular system (which is comprised of the heart and blood vessels), testosterone is responsible for increasing red blood cell production. Although this review is focused primarily on the role of testosterone in men, possible differential effects of the hormone in women must be considered in future studies. Testosterone, the major sex hormone in men, has been a primary candidate in studies of cardiovascular risk. Given the correlation of physical activity with various cardiovascular risk factors, it is unclear whether any observed associations with testosterone level are directly or indirectly mediated by one or more of the risk factors. Ballester et al.81 found that the administration of insulin restores testosterone, LH, and follicle-stimulating hormone levels, indicating that diabetes may cause low testosterone levels. Although all acknowledge the possible cardiovascular risks of testosterone therapy, there is disagreement on the minimum amount of time following a major cardiovascular event that an individual should receive testosterone therapy.35
TRT may not be safe for those with a history of heart failure, heart attacks, or uncontrolled high blood pressure. Some men who take TRT and experience a fast heart rate also report other symptoms. How the body absorbs and processes testosterone can also play a role in how the heart reacts. However, for some, especially those who already have heart problems or high blood pressure, TRT may make the heart work harder.
Other authors have investigated the association between endogenous testosterone levels and the risk of developing T2DM. Ding et al showed that men with T2DM have statistically significant lower levels of total testosterone compared with those in nondiabetics.25 Corona et al confirmed those results by demonstrating that not only total testosterone levels are lower among diabetics, but also the levels of free testosterone and SHBG are lower in diabetic patients.26 By showing that diabetics have reduced levels of free testosterone, Corona et al correctly concluded that the observed reduction in total testosterone in diabetics is not entirely caused by the reduction in SHBG levels.26 Lesser did not provide statistical analysis of his data, and therefore the significance of his findings cannot be validated.48 Other studies from this era also produced similar findings.49 Although most of the earlier studies lacked statistical analysis and their study designs would be considered subpar compared with current standards, the concept that testosterone replacement therapy improves angina has yet to be proven wrong.
http://merchantale.com/reecetubb6519

استعراض الموسيقي

متجر

الموسيقى الخاصة بك

latanyaworkman

الفنانين لمتابعة

المسارات الأسبوعية الأعلى

DJKK1 x Luke Combs - Fast Car [Hype Twerk Redrum] [Clean] 4B 98 🔥🔥🔥

Shy D - Gotta Be Tough

طابور